BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 17852898)

  • 1. Risk factors and outcomes of bloodstream infections with metallo-beta-lactamase-producing Acinetobacter.
    Kim YA; Choi JY; Kim CK; Kim CO; Kim MS; Choi SH; Chin BS; Han SH; Lee HS; Choi HK; Jeoung SJ; Song YG; Yum JH; Yong D; Lee K; Kim JM
    Scand J Infect Dis; 2008; 40(3):234-40. PubMed ID: 17852898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program.
    Mendes RE; Bell JM; Turnidge JD; Castanheira M; Jones RN
    J Antimicrob Chemother; 2009 Jan; 63(1):55-9. PubMed ID: 18957398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antimicrobial resistance and existence of metallo-beta-lactamase in Acinetobacter species isolated from adult patients].
    Eser OK; Ergin A; Hasçelik G
    Mikrobiyol Bul; 2009 Jul; 43(3):383-90. PubMed ID: 19795613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metallo-beta-lactamase-producing Gram-negative bacilli in Korean Nationwide Surveillance of Antimicrobial Resistance group hospitals in 2003: continued prevalence of VIM-producing Pseudomonas spp. and increase of IMP-producing Acinetobacter spp.
    Lee K; Ha GY; Shin BM; Kim JJ; Kang JO; Jang SJ; Yong D; Chong Y;
    Diagn Microbiol Infect Dis; 2004 Sep; 50(1):51-8. PubMed ID: 15380278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence and spread of carbapenem-resistant strains of Acinetobacter baumannii in a tertiary-care hospital in Poland.
    Wroblewska MM; Towner KJ; Marchel H; Luczak M
    Clin Microbiol Infect; 2007 May; 13(5):490-6. PubMed ID: 17331123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors and clinical outcomes of multidrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Thailand.
    Anunnatsiri S; Tonsawan P
    Southeast Asian J Trop Med Public Health; 2011 May; 42(3):693-703. PubMed ID: 21706949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extensively drug-resistant Acinetobacter baumannii: risk factors for acquisition and prevalent OXA-type carbapenemases--a multicentre study.
    Park YS; Lee H; Lee KS; Hwang SS; Cho YK; Kim HY; Uh Y; Chin BS; Han SH; Jeong SH; Lee K; Kim JM
    Int J Antimicrob Agents; 2010 Nov; 36(5):430-5. PubMed ID: 20864318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes and appropriateness of management of nosocomial Acinetobacter bloodstream infections at a teaching hospital in northeastern Malaysia.
    Deris ZZ; Harun A; Shafei MN; Rahman RA; Johari MR
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):140-7. PubMed ID: 19323046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotypic analysis of Acinetobacter bloodstream infection isolates in a Turkish university hospital.
    Alp E; Esel D; Yildiz O; Voss A; Melchers W; Doganay M
    Scand J Infect Dis; 2006; 38(5):335-40. PubMed ID: 16709534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of clinical isolates of Acinetobacter genomospecies 10 carrying two different metallo-beta-lactamases.
    Lee K; Kim CK; Hong SG; Choi J; Song S; Koh E; Yong D; Jeong SH; Yum JH; Docquier JD; Rossolini GM; Chong Y
    Int J Antimicrob Agents; 2010 Sep; 36(3):259-63. PubMed ID: 20599361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bloodstream infections caused by multidrug-resistant Klebsiella pneumoniae producing the carbapenem-hydrolysing VIM-1 metallo-beta-lactamase: first Italian outbreak.
    Cagnacci S; Gualco L; Roveta S; Mannelli S; Borgianni L; Docquier JD; Dodi F; Centanaro M; Debbia E; Marchese A; Rossolini GM
    J Antimicrob Chemother; 2008 Feb; 61(2):296-300. PubMed ID: 18065411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae A case-control study.
    Mosqueda-Gómez JL; Montaño-Loza A; Rolón AL; Cervantes C; Bobadilla-del-Valle JM; Silva-Sánchez J; Garza-Ramos U; Villasís-Keever A; Galindo-Fraga A; Palacios GM; Ponce-de-León A; Sifuentes-Osornio J
    Int J Infect Dis; 2008 Nov; 12(6):653-9. PubMed ID: 18511321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
    Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
    J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of metallo-beta lactamase (MBL) producing Pseudomonas spp. and Acinetobacter spp. in a tertiary care hospital in India.
    Gupta V; Datta P; Chander J
    J Infect; 2006 May; 52(5):311-4. PubMed ID: 16213590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic characterization and colistin susceptibilities of carbapenem-resistant of Pseudomonas aeruginosa and Acinetobacter spp.
    Mohanty S; Maurya V; Gaind R; Deb M
    J Infect Dev Ctries; 2013 Nov; 7(11):880-7. PubMed ID: 24240048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-beta-lactamase in a Greek University Hospital.
    Souli M; Kontopidou FV; Papadomichelakis E; Galani I; Armaganidis A; Giamarellou H
    Clin Infect Dis; 2008 Mar; 46(6):847-54. PubMed ID: 18269335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage.
    Manikal VM; Landman D; Saurina G; Oydna E; Lal H; Quale J
    Clin Infect Dis; 2000 Jul; 31(1):101-6. PubMed ID: 10913404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of and risk factors for Acinetobacter species bloodstream infection in children.
    Segal SC; Zaoutis TE; Kagen J; Shah SS
    Pediatr Infect Dis J; 2007 Oct; 26(10):920-6. PubMed ID: 17901798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.
    Oliveira MS; Prado GV; Costa SF; Grinbaum RS; Levin AS
    J Antimicrob Chemother; 2008 Jun; 61(6):1369-75. PubMed ID: 18367459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cluster of bloodstream infections caused by KPC-2 carbapenemase-producing Klebsiella pneumoniae in Manhattan.
    Nadkarni AS; Schliep T; Khan L; Zeana CB
    Am J Infect Control; 2009 Mar; 37(2):121-6. PubMed ID: 19249638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.